Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packag
Recalled August 3, 2022 · FDA recall D-1292-2022 · Mylan Pharmaceuticals
Hazard
Labeling: Missing label: Label missing from some prefilled pens. · FDA Class I
Units
253,200 pens (50,650/5 per packs)
Sold at
Product was distributed nationwide within the United States
Description
Labeling: Missing label: Label missing from some prefilled pens.
Product
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV
Manufacturer(s)
Mylan Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →